-
Criscuolo E, Diotti RA, Ferrarese R, Alippi C, Viscardi G, Signorelli C, Mancini N, Clementi M, Clementi N, 2021: Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials[J]. Emerg Microbes Infect, 10, 206-210. doi: 10.1080/22221751.2021.1872354
-
Elvis AM, Ekta JS, 2011: Ozone therapy: a clinical review[J]. J Nat Sci Biol Med, 2, 66-70. doi: 10.4103/0976-9668.82319
-
Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K, 2020: Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient[J]. JAMA, 323, 1610-1612. doi: 10.1001/jama.2020.3227
-
Sato H, Wananabe Y, Miyata H, 1990: Virucidal effect of ozone treatment of laboratory animal viruses[J]. Jikken Dobutsu, 39, 223-229.
-
Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA, 2017: Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility[J]. Med Gas Res, 7, 212-219. doi: 10.4103/2045-9912.215752
-
Uhteg K, Jarrett J, Richards M, Howard C, Morehead E, Geahr M, Gluck L, Hanlon A, Ellis B, Kaur H, Simner P, Carroll KC, Mostafa HH, 2020: Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays[J]. J Clin Virol, 127, 104384-. doi: 10.1016/j.jcv.2020.104384
-
van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ, 2020: Aerosol and Surface Stability of SARS-CoV-2 as compared with SARS-CoV-1[J]. N Engl J Med, 382, 1564-1567. doi: 10.1056/NEJMc2004973
-
Zhang JM, Zheng CY, Xiao GF, Zhou YQ, Gao R, 2004: Examination of the efficacy of ozone solution disinfectant in in-activating SARS virus[J]. Chin J Disinfect, 21, 27-28.
-
Zheng X, Wang H, Su Z, Li W, Yang D, Deng F, Chen J, 2020: Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China[J]. J Infect, 81, e128-e129. doi: 10.1016/j.jinf.2020.05.041